Exchange: OTC·Updated 04:00 PM EDT

ELOXD Eloxx Pharmaceuticals Inc

$19.29
$0.70
(3.50%)
Today
Mkt Cap$80.69M
Vol33,943.00

About ELOXD

Eloxx Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of novel ribonucleic acid-modulating drug candidates. It focuses on the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Arlington, MA.
50

Neutral Sentiment

How do you feel about ELOXD?

Advertisement|Remove ads.